Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV7909 for Postexposure Prophylaxis of Anthrax in Healthy Adults
NCT03877926Phase 3Completed
- Sponsor
- Emergent BioSolutions
- Start
- Mar 2019
- Primary completion
- Aug 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of NuThrax in anthrax, sponsored by Emergent BioSolutions. Started Mar 2019; status: completed.
02
Drugs
NuThrax
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT03877926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03877926.